| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |